Symposium at ALS/MND

INNOVATION LANDSCAPE IN ALS/MND:

DESIGNING TOMORROW’S CLINICAL TRIALS TODAY
INCLUSION AND EXCLUSION CRITERIA: A LIVE DEBATE

SATURDAY, DECEMBER 8, 2018

6:45 am — 8:15 am

Breakfast will be served.
Argyll Suite, Crowne Plaza, Glasgow, UK

PROGRAM OBJECTIVES

Review novel technologies for measurement of ALS progression and discuss the potential utility of these innovations
Consider the components of quality of life assessments in patients with ALS and understand their importance in research and in clinical practice
Discuss available and emerging technologies for improving the functioning and quality of life of ALS patients

FACULTY

Carlayne E. Jackson, MD, FAAN

Program Chair
Professor of Neurology and Otolaryngology
UT Health San Antonio, San Antonio, Texas

Julie M. Liss, PhD

Associate Dean, College of Health Solutions
Arizona State University, Tempe, Arizona

Visar S. Berisha, PhD

Assistant Professor, School of Electrical Computer and Energy Engineering
Arizona State University, Tempe, Arizona

Carolyn A. Young, MD, PhD

Consultant Neurologist and Honorary Professor of Neurology at the Walton Centre NHS Trust
University of Liverpool, Liverpool, England

John D. Simeral, PhD

Assistant Professor (Research), School of Engineering
Brown University, Providence, Rhode Island

PROGRAM AGENDA

7:15 PM – 7:45 PM

Registration, Reception, and Dinner

7:45 PM – 8:00 PM

Introduction and Program Overview

Carlayne E. Jackson, MD, FAAN

8:00 PM – 8:20 PM

New Technologies for Measures of Clinical Progression 

Julie M. Liss, PhD and Visar S. Berisha, PhD

8:20 PM – 8:40 PM

Researching the Complexities of Quality of Life in ALS/MND

Carolyn A. Young, MD, PhD

8:40 PM – 9:00 PM

Technological Advancements to Enhance Patient QoL and Maintain Independence

John D. Simeral, PhD

9:00 PM – 9:15 PM

Panel Discussion/Questions and Answers

For questions or inquiries, please contact us at info@alsmndinnovation.com.